Circulating immune checkpoints predict heart failure outcomes

Circulating immune checkpoints predict heart failure outcomes

Abstract Aims There are limited data examining the role of immune checkpoint (IC) ligands in the pathophysiology of heart failure (HF). Therefore, we explore this in three HF animal models and in three different human cohorts (healthy, stable, and worsening HF). Methods and results Transcriptomic an...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Elles M. Screever, Laura I.E. Yousif, Javid J. Moslehi, Joe‐Elie Salem, Adriaan A. Voors, Herman H.W. Silljé, Rudolf A. deBoer, Wouter C. Meijers
Format:	Article
Sprog:	English
Udgivet:	Wiley 2023-08-01
Serier:	ESC Heart Failure
Fag:	Immune checkpoints PD‐L1 PD‐L2 Galectin‐9 Heart failure
Online adgang:	https://doi.org/10.1002/ehf2.14304

Lignende værker

Expression patterns of immune checkpoints in acute myeloid leukemia
af: Cunte Chen, et al.
Udgivet: (2020-04-01)

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study
af: Douglas B. Johnson, et al.
Udgivet: (2019-05-01)

Checkpoint Inhibition in Myeloma: Opportunities and Challenges
af: Federica Costa, et al.
Udgivet: (2018-09-01)

The role of immune checkpoints in cardiovascular disease
af: Laura I. Yousif, et al.
Udgivet: (2022-10-01)

Enhancing cancer care with improved checkpoint inhibitors
af: Vickram A S, et al.
Udgivet: (2024-10-01)

Checkmate with checkpoint inhibitors: New paradigm in immunotherapy
af: Ruby Dhar, et al.
Udgivet: (2023-04-01)

Characterization of PD-1/PD-L1 Immune Checkpoint Expression in Osteosarcoma
af: Kazuhiko Hashimoto, et al.
Udgivet: (2020-07-01)

Immune Checkpoint in Glioblastoma: Promising and Challenging
af: Jing Huang, et al.
Udgivet: (2017-05-01)

Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy
af: Juwon Lee, et al.
Udgivet: (2021-07-01)

Overview of the Cardiotoxicity Induced by PD-1/PD-L1 Immune Checkpoint Inhibitor in Critical Care
af: Ruiting Li, et al.
Udgivet: (2021-06-01)

On Demand Biosensors for Early Diagnosis of Cancer and Immune Checkpoints Blockade Therapy Monitoring from Liquid Biopsy
af: Sai Mummareddy, et al.
Udgivet: (2021-12-01)

PD-1/PD-L1 immune checkpoint inhibitors in glioblastoma: clinical studies, challenges and potential
af: Tianrui Yang, et al.
Udgivet: (2021-02-01)

PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy
af: Jan Willem Kleinovink, et al.
Udgivet: (2017-04-01)

Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases
af: Xin Cai, et al.
Udgivet: (2021-11-01)

Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression
af: Sebastian Marwitz, et al.
Udgivet: (2017-05-01)

Immune Checkpoint Inhibitors in Cancer Therapy
af: Yavar Shiravand, et al.
Udgivet: (2022-04-01)

Immune Checkpoints and Innovative Therapies in Glioblastoma
af: Massimo Romani, et al.
Udgivet: (2018-10-01)

Research Progress on Cardiotoxicity of PD-1/PD-L1 Immune Checkpoint Inhibitors
af: YU Lin, et al.
Udgivet: (2021-08-01)

The Role of Immune Checkpoint Inhibitors in Cancer Therapy
af: Ahmed M. Basudan
Udgivet: (2022-12-01)

The role of immune checkpoint inhibitors in prostate cancer
af: Gabriel Surdacki, et al.
Udgivet: (2019-03-01)

Editorial: The Roles of Checkpoint Inhibitors in Inflammatory Diseases
af: Andreas von Knethen, et al.
Udgivet: (2021-10-01)

Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis
af: Alberto Bongiovanni, et al.
Udgivet: (2021-05-01)

Immune checkpoint blockade therapy for bladder cancer treatment
af: Jayoung Kim
Udgivet: (2016-06-01)

Predictive Biomarkers of Immune Checkpoint Inhibitors-Related Toxicities
af: Ya Xu, et al.
Udgivet: (2020-10-01)

Structural Characterization of a Macrocyclic Peptide Modulator of the PD-1/PD-L1 Immune Checkpoint Axis
af: Edyta Zyla, et al.
Udgivet: (2021-08-01)

The Neonatal Innate Immune Response to Sepsis: Checkpoint Proteins as Novel Mediators of This Response and as Possible Therapeutic/Diagnostic Levers
af: Emily Hensler, et al.
Udgivet: (2022-07-01)

Key questions about the checkpoint blockade-are microRNAs an answer?
af: Mihnea Dragomir, et al.
Udgivet: (2018-06-01)

Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
af: Maria Georganaki, et al.
Udgivet: (2018-12-01)

Enhancement of anti-tumor efficacy of immune checkpoint blockade by alpha-TEA
af: William L. Redmond, et al.
Udgivet: (2023-02-01)

The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors
af: Reid P. Bissonnette, et al.
Udgivet: (2021-08-01)

Advances in immune checkpoint inhibitors for hepatocellular carcinoma
af: Ji Won Han, et al.
Udgivet: (2021-09-01)

Immune Checkpoint Inhibitors: Ctla-4 and Pd-1/Pd-l1 in Immunotherapy
af: Kübra KAHVECİ, et al.
Udgivet: (2019-12-01)

Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation
af: Zachary S. Buchwald, et al.
Udgivet: (2018-12-01)

Safety and efficacy of PD-1/PD-L1 immune checkpoint inhibitors in patients with pre-treated advanced stage malignant mesothelioma: a systematic review and meta-analysis
af: Amjad Zafar, et al.
Udgivet: (2024-11-01)

Immune checkpoint expression and relationships to anti‐PD‐L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young mice
af: Myrna G. Garcia, et al.
Udgivet: (2022-03-01)

The impact of antibiotic use on clinical features and survival outcomes of cancer patients treated with immune checkpoint inhibitors
af: Jiaxin Zhou, et al.
Udgivet: (2022-07-01)

Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
af: Adel Naimi, et al.
Udgivet: (2022-04-01)

Editorial: Biomarkers of Immune-Checkpoint-Inhibitor Immunotherapies in Hepatocellular Carcinomas
af: Zhanjun Guo, et al.
Udgivet: (2022-03-01)

Profiling targetable immune checkpoints in osteosarcoma
af: Troy A McEachron, et al.
Udgivet: (2018-12-01)

The Use of Phytochemicals to Improve the Efficacy of Immune Checkpoint Inhibitors: Opportunities and Challenges
af: Deniz Can Guven, et al.
Udgivet: (2022-10-01)